Impact of the COVID-19 pandemic on statistical design and analysis plans formultidomain intervention clinical trials: Experience fromWorld-Wide FINGERS

1 Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Leipzig, Germany 2 Global Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland 3 National Center for Geriatrics and Gerontology, Obu, Japan 4 Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden 5 Aging Research Center, Center for Alzheimer Research, Department of Neurobiology Care Sciences and Society, Karolinska Institutet and StockholmUniversity, Stockholm, Sweden

[1]  M. Carrillo,et al.  Impact of the COVID‐19 pandemic on statistical design and analysis plans for multidomain intervention clinical trials: Experience from World‐Wide FINGERS , 2021, Alzheimer's & dementia.

[2]  S. Riedel-Heller,et al.  Mental wellbeing in the German old age population largely unaltered during COVID-19 lockdown: results of a representative survey , 2020, BMC Geriatrics.

[3]  J. Steinacker,et al.  Psychological consequences of COVID-19 home confinement: The ECLB-COVID19 multicenter study , 2020, PloS one.

[4]  J. Car,et al.  Associations of Social Isolation with Anxiety and Depression During the Early COVID-19 Pandemic: A Survey of Older Adults in London, UK , 2020, Frontiers in Psychiatry.

[5]  B. Sathian,et al.  Impact of COVID-19 on clinical trials and clinical research: A systematic review , 2020, Nepal journal of epidemiology.

[6]  Aaron van Dorn COVID-19 and readjusting clinical trials , 2020, The Lancet.

[7]  Naaheed Mukadam,et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.

[8]  David L. DeMets,et al.  Achieving effective informed oversight by DMCs in COVID clinical trials , 2020, Journal of Clinical Epidemiology.

[9]  S. Gallina,et al.  Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease , 2020, Nutrition, Metabolism and Cardiovascular Diseases.

[10]  Furberg,et al.  Fundamentals of Clinical Trials, 5th Edition , 2020 .

[11]  A. Newman,et al.  Preserving Clinical Trial Integrity During the Coronavirus Pandemic. , 2020, JAMA.

[12]  D. Heymann,et al.  COVID-19: what is next for public health? , 2020, The Lancet.

[13]  H. Soininen,et al.  Healthy ageing through internet counselling in the elderly (HATICE): a multinational, randomised controlled trial. , 2019, The Lancet. Digital health.

[14]  M. Carrillo,et al.  World-wide fingers network: A global approach to risk reduction and prevention of dementia , 2019, Journal of the Neurological Sciences.

[15]  S. Rapp,et al.  DEMENTIA OUTCOMES AFTER ADDITION OF PROXY-BASED ASSESSMENTS FOR DECEASED OR PROXY-DEPENDENT PARTICIPANTS , 2019, Alzheimer's & Dementia.

[16]  H. Soininen,et al.  The Effect of Multidomain Lifestyle Intervention on Daily Functioning in Older People , 2019, Journal of the American Geriatrics Society.

[17]  H. Soininen,et al.  Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial. , 2018, Journal of Alzheimer's disease : JAD.

[18]  H. Soininen,et al.  World Wide Fingers will advance dementia prevention , 2018, The Lancet Neurology.

[19]  L. Fratiglioni,et al.  The Effect of a 2-Year Intervention Consisting of Diet, Physical Exercise, Cognitive Training, and Monitoring of Vascular Risk on Chronic Morbidity-the FINGER Randomized Controlled Trial. , 2017, Journal of the American Medical Directors Association.

[20]  M. Kivipelto,et al.  Health-related quality of life in a multidomain intervention trial to prevent cognitive decline (FINGER) , 2017 .

[21]  Michael E. Miller,et al.  The effect of intervening hospitalizations on the benefit of structured physical activity in promoting independent mobility among community-living older persons: secondary analysis of a randomized controlled trial , 2017, BMC Medicine.

[22]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[23]  H. Soininen,et al.  Recruitment and Baseline Characteristics of Participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)—A Randomized Controlled Lifestyle Trial † , 2014, International journal of environmental research and public health.

[24]  H. Soininen,et al.  The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress , 2013, Alzheimer's & Dementia.

[25]  Jonathan Krakoff,et al.  Four‐Year Weight Losses in the Look AHEAD Study: Factors Associated With Long‐Term Success , 2011, Obesity.

[26]  Rachael B. Zuckerman,et al.  Measuring the Incidence, Causes, and Repercussions of Protocol Amendments , 2011 .

[27]  S. Evans When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial? , 2007, PLoS clinical trials.